Emergent BioSolutions, Inc. (EBS)
6.77
+0.10
(+1.50%)
USD |
NYSE |
Sep 24, 16:00
6.76
-0.01
(-0.15%)
Pre-Market: 19:59
Emergent BioSolutions Gross Profit (Annual) : 350.60M for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 350.60M |
| December 31, 2024 | 305.20M |
| December 31, 2023 | 292.50M |
| December 31, 2022 | 367.10M |
| December 31, 2021 | 969.90M |
| December 31, 2020 | 1.003B |
| December 31, 2019 | 638.60M |
| December 31, 2018 | 438.20M |
| December 31, 2017 | 364.60M |
| December 31, 2016 | 346.64M |
| December 31, 2015 | 370.96M |
| December 31, 2014 | 334.86M |
| Date | Value |
|---|---|
| December 31, 2013 | 251.35M |
| December 31, 2012 | 232.81M |
| December 31, 2011 | 231.21M |
| December 31, 2010 | 239.06M |
| December 31, 2009 | 188.52M |
| December 31, 2008 | 144.47M |
| December 31, 2007 | 142.61M |
| December 31, 2006 | 128.61M |
| December 31, 2005 | 99.08M |
| December 31, 2004 | 53.39M |
| December 31, 2003 | 33.43M |
| December 31, 2002 | 53.97M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Exelixis, Inc. | 2.236B |
| Capricor Therapeutics, Inc. | -1.890M |
| ADMA Biologics, Inc. | 292.62M |
| Akebia Therapeutics, Inc. | 195.46M |
| Arcutis Biotherapeutics, Inc. | 339.38M |